Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Lavina Lickley"'
Autor:
Sharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, Harriette J Kahn, Arun Seth, Jean-Phillippe Pignol, Lavina Lickley, Lawrence Paszat, Wedad Hanna M.D. FRCPC
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2 (2008)
DCIS is a heterogeneous group of non-invasive cancers of the breast characterized by various degrees of differentiation and unpredictable propensity for transformation into invasive carcinoma. We examined the expression and prognostic value of 9 biol
Externí odkaz:
https://doaj.org/article/cc82661479c0441fa3c0598be1a5bf7f
Autor:
Judith-Anne W. Chapman, Yuejiao Fu, Yan Yuan, William A. Christens-Barry, Jin Qian, H. Lavina Lickley, Naomi A. Miller, David E. Axelrod
Publikováno v:
Cancer Informatics, Vol 6, Pp 99-109 (2008)
Background: Nuclear grade has been associated with breast DCIS recurrence and progression to invasive carcinoma; however, our previous study of a cohort of patients with breast DCIS did not find such an association with outcome. Fifty percent of pati
Externí odkaz:
https://doaj.org/article/af459bf30fb146719c81f865d66fac0a
Effect of Quantitative Nuclear Image Features on Recurrence of Ductal Carcinoma (DCIS) of the Breast
Autor:
David E. Axelrod Ph.D., Naomi A. Miller, H. Lavina Lickley, Jin Qian, William A. Christens-Barry, Yan Yuan, Yuejiao Fu, Judith-Anne W. Chapman Ph.D.
Publikováno v:
Cancer Informatics, Vol 6 (2008)
Background Nuclear grade has been associated with breast DCIS recurrence and progression to invasive carcinoma; however, our previous study of a cohort of patients with breast DCIS did not find such an association with outcome. Fifty percent of patie
Externí odkaz:
https://doaj.org/article/1b99d9f17fc14dfb9627ca0d5645a54f
Autor:
Hanxian Hu, Savannah Cardew, George Tomlinson, Paul E. Goss, Sandhya Pruthi, Lavina Lickley, Sundeep Khosla, Christine Elser, Angela M. Cheung, James N. Ingle, Judy Scher, Sharmila Majumdar, John A Robbins, Moira K. Kapral, Marta C Erlandson, Louise Bordeleau, Lianne Tile, Alice Demaras, Harriet Richardson
Publikováno v:
The Lancet Oncology. 13:275-284
Exemestane can prevent breast cancer in postmenopausal women. Because of potential widespread use, we examined the safety of exemestane on bone health.In this nested safety substudy of the MAP.3 trial (a randomised, placebo-controlled, double-blind t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab325a61e0f151d1b2be22127553a40
https://doi.org/10.1016/s1470-2045(11)70389-8
https://doi.org/10.1016/s1470-2045(11)70389-8
Publikováno v:
Cancer. 95:236-242
BACKGROUND Many women who are at an elevated risk of developing breast carcinoma choose prophylactic mastectomy to decrease their risk. We conducted a population-based study to review the indications for, and patterns of practice of prophylactic mast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c691ac7d5d28e0cbaef0b36b024b3bb0
https://doi.org/10.1002/cncr.10680
https://doi.org/10.1002/cncr.10680
Autor:
Gloria E. Sarto, Silvana Spadafora, Kendrith M. Rowland, Karen A. Gelmon, Carol J. Fabian, Elizabeth Maunsell, Dongsheng Tu, Angela M. Cheung, Susan L. Hendrix, Sandhya Pruthi, Lavina Lickley, Amparao Ruiz, Jean Wactawski-Wende, Andrew Cooke, Harriet Richardson, Joseph L. Pater, Pascal Pujol, Andrea Hiltz, Michael Brundage, Debra W. Thayer, José E. Alés-Martínez, Pierre Dubé, Rowan T. Chlebowski, Paul E. Goss, Susan Ellard, James N. Ingle, D. Johnston
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(14)
Purpose Exemestane, a steroidal aromatase inhibitor, reduced invasive breast cancer incidence by 65% among 4,560 postmenopausal women randomly assigned to exemestane (25 mg per day) compared with placebo in the National Cancer Institute of Canada (NC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02fa27d714a7e4ec2527ed4cbaeaafeb
https://pubmed.ncbi.nlm.nih.gov/25154832
https://pubmed.ncbi.nlm.nih.gov/25154832
Autor:
R Wilkinson, Wedad Hanna, S Mariz, Martin E. Blackstein, David R. McCready, William R. Geddie, Saul Sidlofsky, A Katz, P Dacamara, M Baida, G Stoik, Lavina Lickley, R W Hartwick, M Lipa, D Strongitharm, Donald J.A. Sutherland, Irene L. Andrulis, H Weizel, A Qizilbash, U Ambus, Kenneth P.H. Pritzker, C Mak, Shelley B. Bull
Publikováno v:
Journal of Clinical Oncology. 16:1340-1349
PURPOSE It remains a challenge to predict which women with axillary node-negative (ANN) breast cancer at greatest risk of relapse may benefit most from adjuvant therapy. Increases in neu/erbB-2 have been implicated in breast cancer prognosis. Althoug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427fccecc2ecf18272c8f245371eb37f
https://doi.org/10.1200/jco.1998.16.4.1340
https://doi.org/10.1200/jco.1998.16.4.1340
Autor:
Sharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, Harriette J Kahn, Arun Seth, Jean-Phillippe Pignol, Lavina Lickley, Lawrence Paszat, Wedad Hanna
Publikováno v:
Clinical Medicine. Oncology
Clinical Medicine Insights: Oncology, Vol 2 (2008)
Clinical Medicine Insights: Oncology, Vol 2 (2008)
DCIS is a heterogeneous group of non-invasive cancers of the breast characterized by various degrees of differentiation and unpredictable propensity for transformation into invasive carcinoma. We examined the expression and prognostic value of 9 biol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a23f0c20f5850243629f9598833402
https://pubmed.ncbi.nlm.nih.gov/21892261
https://pubmed.ncbi.nlm.nih.gov/21892261
Autor:
Lavina Lickley, Wedad Hanna, Rebecca Dent, Kathleen I. Pritchard, Carol Sawka, Steven A. Narod, Harriet K. Kahn, Ping Sun, Ellen Rawlinson, Maureen E. Trudeau
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 13(15 Pt 1)
Purpose: To compare the clinical features, natural history, and outcomes for women with “triple-negative” breast cancer with women with other types of breast cancer. Experimental Design: We studied a cohort of 1,601 patients with breast cancer, d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92dffa071598568167f48568192cfecc
https://pubmed.ncbi.nlm.nih.gov/26330504
https://pubmed.ncbi.nlm.nih.gov/26330504
Autor:
Claire M. B. Holloway, Daniel Maclean, Harriette J. Kahn, Lu-Ying Yang, John Blondal, Maureen Trudeau, Lavina Lickley, Anthony Presta, Alexander Marks, David R. McCready
Publikováno v:
Breast cancer research and treatment. 86(3)
The biological and clinical significance of circulating tumor cells (CTC) in the peripheral blood of breast cancer patients is not known. To study this question, we used a direct visualization assay to correlate the number of CTC with disease stage a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2408868034e2f0c656f38df71bebc77b
https://pubmed.ncbi.nlm.nih.gov/15567940
https://pubmed.ncbi.nlm.nih.gov/15567940